Nafloxin (Ciprofloxacin)

Ciprofloxacin, the active ingredient in Nafloxin, is a fluoroquinolone presented as an intravenous formulation for hospital use. It targets a broad range of Gram‑negative bacteria and is employed in the treatment of serious infections in adult patients. The drug works by inhibiting bacterial DNA replication, making it effective for urinary, respiratory, skin and intra‑abdominal infections where susceptible organisms are identified.

GNH USA supplies Nafloxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics, ensuring consistent quality and regulatory compliance across markets worldwide.

Nafloxin (ciprofloxacin) is used to treat infections caused by susceptible Gram‑negative bacteria across several organ systems. - Urinary tract infections: effective for acute uncomplicated and complicated UTIs caused by ciprofloxacin‑sensitive organisms. - Respiratory tract infections: treats community‑acquired pneumonia and acute exacerbations of chronic bronchitis when the pathogen is susceptible. - Skin and soft‑tissue infections: used for cellulitis, wound infections and diabetic foot infections caused by Gram‑negative bacteria. - Intra‑abdominal infections: indicated for peritonitis, intra‑abdominal abscesses and postoperative infections with susceptible organisms. - Gram‑negative bacterial infections: broad coverage for sepsis and bacteremia due to Enterobacteriaceae and Pseudomonas aeruginosa.

Ciprofloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmias. - Severe hypersensitivity: anaphylaxis, Stevens‑Johnson syndrome. - Clostridioides difficile infection: colitis secondary to gut flora disruption.

When prescribing Nafloxin, clinicians should observe several precautionary measures to minimize risks. - Renal function: adjust use in patients with impaired kidney function and monitor serum creatinine. - CNS effects: be aware of possible dizziness, seizures or confusion, especially in the elderly. - Phototoxicity: advise patients to avoid excessive sunlight or UV exposure during therapy. - Drug resistance: limit use to infections with confirmed susceptibility to reduce resistance development. - Pregnancy and lactation: use only if clearly needed; benefits must outweigh potential fetal or neonatal risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Ciprofloxacin can interact with several medicines, altering its efficacy or increasing toxicity.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: reduce ciprofloxacin absorption; separate administration by at least 2 hours. - Warfarin: may enhance anticoagulant effect, increasing INR; monitor coagulation parameters closely. - Theophylline: ciprofloxacin can raise serum theophylline levels, risking toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): may increase risk of central nervous system stimulation and seizures. - Diabetic agents (e.g., insulin, sulfonylureas): ciprofloxacin may potentiate hypoglycemia; monitor blood glucose. - Corticosteroids: combined use may raise risk of tendon rupture; advise caution.